Academy of Military Medical Science

Slides:



Advertisements
Similar presentations
© 2004 by Thomson Delmar Learning, a part of the Thomson Corporation. Fundamentals of Pharmacology for Veterinary Technicians Chapter 21 Vaccines.
Advertisements

Noël TORDO CANINE ADENOVIRUS- BASED VACCINES AGAINST RABIES working together to stop the ongoing tragedy of rabies!
1 Molecular epidemiology of lyssaviruses in Eurasia Dr Lorraine McElhinney Veterinary Laboratories Agency (Weybridge), UK.
IMMUNOGENICITY OF ERA G 333 STRAIN
Towards the elimination of rabies in Eurasia, Paris, May Efficacy of a square presentation of V-RG vaccine baits in red fox, domestic dog.
1 1 FGI Federal Centre for Animal Health, Vladimir, Russia 2 Finnish Food Safety Authority Evira 3 Helsinki University, Helsinki, Finland FINNISH-RUSSIAN.
NATIONAL VETERINARY RESEARCH INSTITUTE, PULAWY, POLAND Towards the Elimination of Rabies in Eurasia, Paris, May 2007 RABIES SURVEILLANCE IN POLAND.
Inhibition of rabies virus replication by microRNA N.ISRASENA, N. RATANASETYUTH, P.SUPAVONWONG, P. VIROJANAPIROM, T.HEMACHUDHA Department of Pharmacology,
SYLVATIC RABIES IN RUSSIA WITH SPECIAL ATTENTION TO PERSPECTIVES OF ORAL VACCINATION OF WILD CARNIVORES A. Botvinkin, D. Bankovsky, G. Safonov Irkutsk.
1 Towards the elimination of Rabies in Eurasia Jean Blancou, WOAH, May
Bernhard Dietzschold Thomas Jefferson University Paris, France May 2007 Dominance of a non-pathogenic over a pathogenic glycoprotein gene in rabies virus.
Option F: Microbes and Biotechnology F.3 Microbes and Biotechnology.
Lecture 26. Prevention and Control -- Vaccines
Designing and Optimizing an Adenovirus Encoded VLP Vaccine against HIV Anne-Marie Andersson PhD Student, University of Copenhagen.
Vaccines Robert Beatty MCB150. Passive vs Active Immunity  Passive immunization transfer of antibodies  Vaccines are active immunizations (mimic natural.
Chapter 12-Vaccines Traditional vs. rDNA vaccines Subunit vaccines Peptide vaccines Genetic immunization: DNA vaccines Attenuated vaccines Vector vaccines.
Prof. Fatma Amer Medical Microbiology and Immunology, ZAGAZIG FACULTY OF Medicine, Egypt President of ISC/HWG President of ArAPUA In the Era of Direct.
1 Vaccines  A vaccine is a biological preparation that improves immunity to a particular disease. During vaccination, a vaccine is injected or given orally.
Chapter 12-Vaccines Traditional vs. rDNA vaccines Subunit vaccines
Biosafety and recombinant DNA technology. Involves.... Experiments involving the construction or use of GMOs should be conducted after performing a biosafety.
VACCINATION. Vaccination: Is The administration of an antigen to stimulate a protective immune response against an infectious agent.
Preparation and Evaluation of an Inactivated Multi-Strain PRRS Vaccine Made with Viruses Isolated from Vietnam Central Vietnam Veterinary Institute This.
Genetic Engineering What is Genetic Engineering? Genetic Engineering = inserting a foreign gene of interest into a host to transcribe and translate a.
Types of vaccines 1 - First generation vaccines are whole-organism vaccines - either live and weakened, or killed forms. [1] Live, attenuated vaccines,
Novel strategies for prevention and treatment of HIV infection Prasit Faipenkhong Pairoaj Vonghathaipaisarn Rodjana Chunhabundit Zhang Jianjun.
Central Vietnam Veterinary Institute
STATENS SERUM INSTITUT DNA Vaccination Anneline Nansen Department of Infectious Disease Immunology Statens Serum Institut (SSI)
Display of the Viral Epitopes on Lactococcus lactis: A Model for Food Grade Vaccine against EV71.
Making Vaccines.
TYPES OF CLONING VECTORS
Dr Hannah Kibuuka Makerere University Walter Reed Project Presentation at the Uganda Medical Association-Uganda Veterinary Association joint conference.
Adapted from: Project Lead The Way Making Vaccines powerpoint
Oncolytic Viruses “Onco” = cancer “Lytic” = killing An innovative cancer therapy that seeks to harness the natural properties of viruses to aid in the.
Phagocyte. B cells Receptor B Cell Naïve B cell B cells and antibodies daughter cells produce antibodies phagocyte consumes an antibody coated virus.
A vaccine is biological preparation that improves immunity to a particular disease, a vaccine typically contains a disease causing micro-organisms often.
Viral Vaccine Types Viruses are inactivated with chemicals such as formaldehyde. Inactivated (killed) vaccines cannot cause an infection, but they.
Copyright © 2010 Pearson Education, Inc. Lectures prepared by Christine L. Case Chapter 9 Biotechnology and Recombinant DNA.
ANIMAL MODELS FOR HIV VACCINES Girish N. Vyas, Ph.D. UCSF School of Medicine, San Francisco (UCSF) A quote from the keynote Address at the January, 2008.
Biotechnology Practice Test. Question #1 An organism’s chromosomes are part of its a) plasmid b) recombinant DNA c) genome d) enzymes.
John R. LaMontagne Memorial Symposium on Pandemic Influenza Research April 4-5, 2005 Institute of Medicine Working Group Five: Immunology, Assay Standardization,
Recombinant DNA What is the basis of recombinant DNA technology? How does one “clone” a gene? How are genetically modified organisms (GMOs) created? Illustration.
Infection and Disease Fungi Parasites Nosocomial infection Diagnosis of infectious disease.
Biotechnology Vaccines Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel:
Microbial Models I: Genetics of Viruses and Bacteria 8 November, 2004 Text Chapter 18.
Making Vaccines. Effective Vaccines Have low levels of side effects or toxicity. Protect against exposure to natural, or wild forms of the pathogen. Should.
Gene therapy and viral vectors
Types of cloning vectors 1. Plasmids: Autonomously replicating circular DNA molecules. 2.Bacteriophage: Small viruses that infect bacteria cells. 3. Vectors.
CATEGORY: VACCINES & THERAPEUTICS HIV-1 Vaccines Shokouh Makvandi-Nejad, University of Oxford, UK HIV-1 Vaccines © The copyright for this work resides.
Viral vaccines  .
Vaccine; To be effective  Must stimulate as many of the body's defence mechanisms as possible.  It is not necessary to get 100% uptake of vaccine in.
COPY CHOICE RECOMBINATION
HIV-1 Vaccines Shokouh Makvandi-Nejad, University of Oxford, UK
Moral Monday BW Should patients be given refunds when a vaccine doesn’t work?
Chapter 12-Vaccines Traditional vs. rDNA vaccines Subunit vaccines
Biotechnology Practice Test
Chapter 7-Vaccines Vaccination Current and future vaccines
Even 2,500 Years Ago, People Knew Immunity Worked.
Immunology & Public Health
Making Vaccines.
Presentation Topic Cloning Vector and its Types Presented By
DNA VACCINES.
US Army Medical Research and Materiel Command
? Neutralizing Antibodies: Research pathways in 2013 and beyond
DEVELOPMENT OF A NOVEL VNT ASSAY USING QRT-PCR-BASED ENDPOINT ASSESSMENT FOR RAPID DETECTION AND TITRATION OF NEUTRALIZING ANTIBODIES AGAINST FMDV.
A brief discussion on passive and active (esp., vaccines) immunity
Δcarp mutants have a growth phenotype in vitro and in vivo.
Challenges, Consideration, and Progress
Simplified representation of the reverse genetic approach used to construct the chimera vaccine Poulvac FluFend i AI H5N3 RG to protect poultry against.
VACCINATION. Vaccination: Is The administration of an antigen to stimulate a protective immune response against an infectious agent.
Presentation transcript:

Academy of Military Medical Science Vaccination of dogs using a recombinant canine adenovirus type-2 viral vector confers long-lasting immunity against rabies Veterinary Institute Academy of Military Medical Science Changchun, Jilin, China 28 May, 2007 Paris

Human rabies in China in the most recent decade 159 222 229 343 495 891 1191 2037 2651 2548 3215 500 1000 1500 2000 2500 3000 3500 1996 1997 1998 1999 2002 2003 2004 2005 2006 2001 Year Human rabies in China in the most recent decade Human rabies cases geological distribution in China

Rabies reservoir or vectors in China Dogs: 98% Cats: 4-5% Badger: 15 cases were reported Rats: in some areas in the south of China Foxes: Inner Mongolia Wolves: Xinjiang Bats:?

Vaccines for dogs in China ERA: in five combined vaccines Flury LEP: approved for two years Inactivated (imported) : Intervet, Merial, Fort Dodge Inactivated (home-made): 3-4 types, in clinical trial, not yet approved * Vaccination of inactivated vaccine in rural areas needs laborious work.

Oral vaccines for dogs Attenuated or mutated live rabies virus SAD-B19 SAG1 SAG2 reverse genetically modified …… Recombinant live virus vector Poxvirus-vector based Adenovirus-vector based

Advantages of adenovirus Safe Wide range of host Heat stable (Oral infection) Median package of a foreign gene Persistent existence ?

Adenovirus Hu RL et al. Microbes Infect, 2006, 8(4): 1090-1097 Liu Y, Hu R, Zhang S, et al Viral Immunology, 2006(19), 2:202-209 Patent1: 20041001097.8 Patent2: 20041001200.3 Non-essential for replication Foreign gene or label inserts Fiber pIX

Strategies for recombinant virus construction Homologous recombination Gene cloning

Our constructs Glycoprotein: SRV9 CVS-24 8202(street strain) Nucleoprotein: The recombinant CAV-2 genome containing the rabies virus glycoprotein expression cassette in plasmid form

Production of the recombinant virus MDCK cells CPE Western blot analysis Handling of canine adenovirus (safe) MDCK easy grown Obvious CPE High titer: around 10(8.5)

Bait composition Five parts: the recombinant virus solution; pledget; tallow; metal frame; paper package

Bait uptake

Vaccination and antibody induction in dogs Inoculation routes Total No. dogs Take the baits or vaccinated Develop neutralizing antibody Antibody last for 2 years at a protective level Bait (oral) 96 90/96 79/90 (87.8%) 72/90(80.0%) Solution (intranasal) 46 46/46 40/46 (87.0%) 36/46(78.3%)

Antibody production and persistence

Challenge results of dogs orally vaccinated and the negative controls Groups Number of dogs died after different time of vaccination Dogs survived 1 week 2 weeks 3 weeks 4 weeks 5 weeks Orally vaccinated 10 Negative control 6 3 1

Prospect In cats In pigs In cattle and more Dogs Bats

Conclusions A new, safe and efficacious rabies vaccine A simple and useful bait For oral use Long lasting immunization in dogs